rs137905181

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS1

The NM_014363.6(SACS):​c.9562T>C​(p.Phe3188Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000206 in 1,609,818 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00030 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00020 ( 1 hom. )

Consequence

SACS
NM_014363.6 missense

Scores

6
10
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:2

Conservation

PhyloP100: 8.87

Publications

5 publications found
Variant links:
Genes affected
SACS (HGNC:10519): (sacsin molecular chaperone) This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
SACS Gene-Disease associations (from GenCC):
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, PanelApp Australia, G2P, Myriad Women’s Health, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.21307245).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000302 (46/152286) while in subpopulation AMR AF = 0.00209 (32/15292). AF 95% confidence interval is 0.00152. There are 0 homozygotes in GnomAd4. There are 20 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014363.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
NM_014363.6
MANE Select
c.9562T>Cp.Phe3188Leu
missense
Exon 10 of 10NP_055178.3
SACS
NM_001437336.1
c.9589T>Cp.Phe3197Leu
missense
Exon 11 of 11NP_001424265.1A0A804HIQ1
SACS
NM_001278055.2
c.9121T>Cp.Phe3041Leu
missense
Exon 8 of 8NP_001264984.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
ENST00000382292.9
TSL:5 MANE Select
c.9562T>Cp.Phe3188Leu
missense
Exon 10 of 10ENSP00000371729.3Q9NZJ4-1
SACS
ENST00000455470.6
TSL:1
c.2432-4830T>C
intron
N/AENSP00000406565.2H0Y6M8
SACS
ENST00000682944.1
c.9589T>Cp.Phe3197Leu
missense
Exon 11 of 11ENSP00000507173.1A0A804HIQ1

Frequencies

GnomAD3 genomes
AF:
0.000302
AC:
46
AN:
152168
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00210
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000283
AC:
70
AN:
247244
AF XY:
0.000209
show subpopulations
Gnomad AFR exome
AF:
0.0000637
Gnomad AMR exome
AF:
0.000497
Gnomad ASJ exome
AF:
0.000802
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000340
Gnomad OTH exome
AF:
0.000999
GnomAD4 exome
AF:
0.000196
AC:
286
AN:
1457532
Hom.:
1
Cov.:
37
AF XY:
0.000178
AC XY:
129
AN XY:
724772
show subpopulations
African (AFR)
AF:
0.0000301
AC:
1
AN:
33212
American (AMR)
AF:
0.000630
AC:
28
AN:
44430
Ashkenazi Jewish (ASJ)
AF:
0.000652
AC:
17
AN:
26064
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39532
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85586
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53196
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5714
European-Non Finnish (NFE)
AF:
0.000202
AC:
224
AN:
1109616
Other (OTH)
AF:
0.000266
AC:
16
AN:
60182
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
19
39
58
78
97
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000302
AC:
46
AN:
152286
Hom.:
0
Cov.:
33
AF XY:
0.000269
AC XY:
20
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41578
American (AMR)
AF:
0.00209
AC:
32
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
68002
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000292
Hom.:
0
Bravo
AF:
0.000472
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000231
AC:
28
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
1
Charlevoix-Saguenay spastic ataxia (4)
-
2
-
not provided (2)
-
-
1
Spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Pathogenic
0.25
D
BayesDel_noAF
Pathogenic
0.46
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.64
D
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.62
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.93
D
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.21
T
MetaSVM
Uncertain
0.46
D
MutationAssessor
Benign
1.1
L
PhyloP100
8.9
PrimateAI
Uncertain
0.76
T
PROVEAN
Uncertain
-3.9
D
REVEL
Pathogenic
0.80
Sift
Uncertain
0.021
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.98
D
Vest4
0.95
MutPred
0.54
Gain of catalytic residue at N3190 (P = 0.003)
MVP
0.92
ClinPred
0.15
T
GERP RS
5.5
Varity_R
0.72
gMVP
0.79
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137905181; hg19: chr13-23908453; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.